Kenan Midilli

Kenan Midilli

Auto-generated profile, based on publicly available information

Kenan Midilli

Istanbul Univ, Cerrahpasa Fac Med, Dept Med Microbiol, Istanbul, Turkiye

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2007 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
KMKenan Midilli
Kenan Midilli
AGAYSEN GARGILI
AYSEN GARGILI
Onder ErgonulOnder Ergonul
Onder Ergonul
GŞGönül Şengöz
Gönül Şengöz
RORecep Ozturk
Recep Ozturk
FJFrans Jongejan
Frans Jongejan
We described a series of imported cases of Crimean-Congo Hemorrhagic Fever (CCHF) in Istanbul and investigated the genetic diversity of the virus. All the suspected cases of CCHF, who were applied to the health centers in Istanbul, were screened for CCHF virus (CCHFv) infection by using semi-nested Polymerase Chain Reaction (PCR) following RT-PCR. Simultaneous blood samples were also sent to the national reference laboratory in Ankara for serologic investigation. In 10 out of 91 patients, CCHFv was detected by PCR, and among 9 out of 10, anti-CCHFv IgM antibodies were also positive. Clinical features were characterized by fever, myalgia, and hemorrhage. The levels of liver enzymes, creatinine phosphokinase, and lactate dehydrogenase were elevated, and bleeding markers were prolonged. All the cases were treated with ribavirin. There was no fatal case. All the strains clustered within the same group as other Europe/Turkey isolates.

17 December 2015 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
MBMehmet Bakir
Mehmet Bakir
AEAynur Engin
Aynur Engin
MKMert Ahmet Kuskucu
Mert Ahmet Kuskucu
SBSevtap Bakir
Sevtap Bakir
OGOmür Gündag
Omür Gündag
KMKenan Midilli
Kenan Midilli

1 March 2017 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
AKAsiye Karakullukçu
Asiye Karakullukçu
MKMert Ahmet Kuşkucu
Mert Ahmet Kuşkucu
SESevgi Ergin
Sevgi Ergin
GAGökhan Aygün
Gökhan Aygün
KMKenan Midilli
Kenan Midilli
ÖKÖmer Küçükbasmaci
Ömer Küçükbasmaci

16 February 2015 in Balkan Medical Journal
Verified
Journal Article
Open access
LSLeyla Sirekbasan
Leyla Sirekbasan
NGNevriye Gonullu
Nevriye Gonullu
Serhat SirekbasanSerhat Sirekbasan
Serhat Sirekbasan
MKMert Kuskucu
Mert Kuskucu
KMKenan Midilli
Kenan Midilli
Macrolide resistance in Streptococcus pneumoniae (S. pneumoniae) is a worldwide problem. The aim of this work was to analyze the phenotypes, genotypes, and clonal relatedness among macrolide-resistant S. pneumoniae strains isolated from various clinical specimens in our hospital. Cross-sectional study. 80 non-duplicate S. pneumoniae strains were analyzed by polymerase chain reaction for both the erm (B) and mef (A) genes. Macrolide resistance was observed in 22.5% (18 strains) of strains. Two (11.2%) isolates possessed mef (A), eight possessed erm (B) (44.4%) and eight strains (44.4%) were positive for both erm (B) and mef (A) genes. Although BOX-PCR of 18 macrolide-resistant strains revealed 11 band patterns, they clustered as seven clones with a genetic distance >10% to each other. Eight isolates possessed both erm (B) and mef (A) genes and belonged to a single clone (44.44% of all macrolide-resistant strains). Increased positivity rates for both resistance genes have also been reported from other hospitals in Turkey, but this is the first study from Turkey showing the clonal dissemination of both resistance genes.

19 November 2015 in Biotechnology & Biotechnological Equipment
Verified
Journal Article
Open access
MAMustafa Altindis
Mustafa Altindis
TDTuba Dal
Tuba Dal
IAIsin Akyar
Isin Akyar
OKOnur Karatuna
Onur Karatuna
SGSelma Gokahmetoglu
Selma Gokahmetoglu
HGHuseyin Guducuoglu
Huseyin Guducuoglu
Hepatitis C infection is a public health problem. The aim of this retrospective study was to determine the distribution of hepatitis C virus (HCV) genotypes in seven regions of Turkey, by evaluating 7002 patients with chronic HCV in a six-year period. During the 2009–2014 period, serum/plasma samples from 7002 new consecutive HCV RNA positive patients were collected. The female patients were 3867 (55.2%). The genotype distribution of HCV patiens was evaluated by ages and years. Statistical analysis was performed by using the Mann–Whitney test and the χ2 analysis. During the six-year period, genotype 1b was the most common genotype (67.7%) followed by untypeable genotype 1 (7.7%), genotype 4 (7.3%) and genotype 3 (6.7%). In 2014, genotype 3 was the second most common one (11.3%) and genotype 4 was the third most common one (9.8%). In the group with <25 years old patients, genotype 1b was most common (78.48%, 62/79) between the years of 2009 and 2011, whereas genotype 3 (34.8%, 86/247), between the years of 2012 and 2014. Genotype 1b was the most common in the groups between 26 and 35 years, 36 and 45 years, 46 and 55 years, 56 and 65 years. The rate of genotype 3 was increased from 4.78% to 10.06% and the rate of genotype 4 was increased from 1.3% to 3.84%, from 2009–2011 to 2012–2014. In recent years, genotypes 3 and 4 have gained importance. New therapeutic strategies and survey studies may be required for the modified HCV genotype pattern.

1 September 2021 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
AEAhmet Emre Eskazan
Ahmet Emre Eskazan
IBİlKer İnAnç Balkan
İlKer İnAnç Balkan
KDKaan Can Demirbaş
Kaan Can Demirbaş
MAMuhlis Cem Ar
Muhlis Cem Ar
RKRıdvan Karaali
Rıdvan Karaali
FTFehmi Tabak
Fehmi Tabak